Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China flag China · Delayed Price · Currency is CNY
27.96
-0.08 (-0.29%)
Apr 29, 2026, 3:00 PM CST

SHA:688566 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
253.46261219.33219.09154.67114.9
Depreciation & Amortization
17.7717.7710.611.212.7512.98
Other Amortization
0.690.690.891.071.091.09
Loss (Gain) From Sale of Assets
----0.01-
Asset Writedown & Restructuring Costs
0.010.0142.24---
Loss (Gain) From Sale of Investments
0.810.81-1.390.48-5.68-17.26
Provision & Write-off of Bad Debts
--2.267.20.73-1.77
Other Operating Activities
-62.12-3.69-0.591.81-0.4-0.55
Change in Accounts Receivable
-61-61-24.28-138.14-72.0842.96
Change in Inventory
3.613.61-1.191.12-0.830.28
Change in Accounts Payable
11.5811.58-37.638.4739.43-8.6
Change in Other Net Operating Assets
23.0323.036.8117.8921.517.33
Operating Cash Flow
182.34248.3215.29159.5150.72150.56
Operating Cash Flow Growth
2.79%15.33%34.98%5.82%0.11%28.28%
Capital Expenditures
-111.35-114.6-174.53-357.37-292.7-83.79
Sale of Property, Plant & Equipment
00--0.010
Cash Acquisitions
-20.38-20.38----
Investment in Securities
-5-10-51-15108.8-270
Other Investing Activities
67.8-129.65.368.338.4120.64
Investing Cash Flow
-68.92-274.57-220.17-364.04-175.49-333.15
Short-Term Debt Issued
--39.2619.74--
Total Debt Issued
--39.2619.74--
Total Debt Repaid
-2.2-----
Net Debt Issued (Repaid)
-2.2-39.2619.74--
Issuance of Common Stock
--222.2924.29--
Common Dividends Paid
-103.71-103.7-102.95-44.87-89.73-89.73
Other Financing Activities
52.5963.85-1.31-0.4--
Financing Cash Flow
-53.32-39.86157.3-1.23-89.73-89.73
Net Cash Flow
60.1-66.13152.42-205.77-114.5-272.32
Free Cash Flow
70.99133.7140.76-197.87-141.9866.77
Free Cash Flow Growth
306.03%228.01%----28.73%
Free Cash Flow Margin
7.17%13.84%4.55%-22.98%-21.68%13.10%
Free Cash Flow Per Share
0.350.670.21-1.06-0.760.35
Cash Income Tax Paid
167.44152.97141.4293.8383.3683.52
Levered Free Cash Flow
-46.3320.19-12.08-303.05-187.7385.4
Unlevered Free Cash Flow
-46.3320.19-12-302.99-187.585.4
Change in Working Capital
-28.28-28.28-58.05-81.35-12.4441.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.